Bioalternatives has initiated a tissue engineering R&D program in order to develop a skin equivalent model incorporating melanoma cells.
After different tests on monolayer cultures, two cancer lines issued from melanomas (among those available in Bioalternatives) were selected to be integrated as standard in a normal skin equivalent model (3D culture):
3D cell culture has allowed us to obtain 2 models corresponding to different stages of development and severity, in which:
Beatrice Wihlander 11 June 2025 Givaudan is showcasing its fragrance technologies, which are underscored by…
After over 10 years of testing sunscreen products, at Zurko Research we are proud to…
Mack Degueurin 22 April 2025 The wearable device analyzes the tiny changes in physical responses…